INTERVIEW: Swiss pharma industry warns US tariff threat still looms
Editorial abstract
Tariffs on medicines could soon be back on the table, with or without Trump.
This is not the publisher’s original article. Unreviewed abstracts are mechanically condensed from source-provided material; editor-reviewed abstracts have completed editorial review.Story classification
Topics
US–China Competition and Supply-Chain Security · High confidence · AutomaticStory-text match
War, Deterrence, and Regional Escalation · High confidence · AutomaticStory-text match
Regions
Europe · Low confidence · AutomaticBroad source default; editorial correction recommended